Latest Innovation News

Dubber Corporation has confirmed it will retain its key contract with Virgin Media O2, securing guaranteed revenues for FY26 while implementing significant cost reductions to return to cash flow positivity by year-end.

Proteomics International has completed a $12 million capital raise, including a heavily oversubscribed Share Purchase Plan, to fast-track the rollout of its innovative diagnostic tests in Australia and the USA.

PainChek has advanced its US regulatory approval process with a positive FDA meeting, setting the stage for a potential market debut of its pain assessment app in late 2025.

Catapult Group International has acquired Perch, an AI-driven athlete monitoring startup, for US$18 million, enhancing its Performance & Health vertical without raising capital. This move integrates gym-based strength data with on-field analytics, promising a more comprehensive sports technology platform.

IperionX has secured a significant U.S. Department of Defense contract worth up to US$99 million to supply low-cost, high-performance titanium components, marking a major step in reshoring critical materials manufacturing.

Locate Technologies has made a strategic move by investing A$1 million in Bitcoin, aiming to leverage cryptocurrency as a growth catalyst while continuing to advance its core delivery platforms.

Cardiex Limited has successfully raised $2.4 million through an institutional placement to boost manufacturing and commercial activities for its CONNEQT Pulse device.

Anagenics Limited’s proprietary hair regrowth technology powers the newly launched Bouf Haircare brand, which has achieved over $500,000 in sales in its first week, setting the stage for a lucrative royalty stream.

OncoSil Medical has launched a Security Purchase Plan offering discounted shares and free options to eligible shareholders, aiming to accelerate commercialization of its pancreatic cancer treatment device.

ClearVue Technologies’ subsidiary OptiCrop has secured its inaugural commercial project, an $80,000 greenhouse installation leveraging proprietary ground-source heat exchange technology. This milestone underscores ClearVue’s strategic expansion into sustainable protected cropping and greenhouse agriculture.

Chimeric Therapeutics has secured FDA Fast Track designation for its CHM CDH17 CAR-T therapy targeting gastroenteropancreatic neuroendocrine tumours, accelerating its path toward regulatory approval and patient access.

BetMakers Technology Group is poised to expand its North American footprint by acquiring LVDC, Nevada’s exclusive pari-mutuel wagering provider, targeting an initial A$4 million in annual revenue.